Anti-vascular endothelial growth factor therapy in retinopathy of prematurity: An updated literature review

Laser photocoagulation can still be considered the gold standard for treatment for retinopathy of prematurity (ROP). However, anti-vascular endothelial growth factor (anti-VEGF) therapy has increasingly become an important option that plays a significant role in the treatment of ROP. Major clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Alzuabi, Asma K., Alshammari, Ola M., Almousa, Abdullah N., Abouammoh, Marwan A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Update on Retinopathy of Prematurity
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583351/
https://www.ncbi.nlm.nih.gov/pubmed/36276253
http://dx.doi.org/10.4103/sjopt.sjopt_12_22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583351/
https://www.ncbi.nlm.nih.gov/pubmed/36276253
http://dx.doi.org/10.4103/sjopt.sjopt_12_22

Ejemplares similares